Back to People
Anne Wojcicki

Anne Wojcicki

Born 1973 · Age 52

American entrepreneur, co-founder and former CEO of personal genomics company 23andMe. Yale-educated biologist who moved from healthcare investment to consumer genomics; led major partnerships, a SPAC public listing and later faced company valuation collapse and bankruptcy proceedings.

Total Events
42
Career Span
52 years
Peak Net Worth
$1,000,000,000

Compare Your Trajectory

See how your career milestones stack up against Anne Wojcicki and other industry leaders.

Life & Career Timeline

1973Age 0

Born in Palo Alto / San Mateo County, California

Anne E. Wojcicki was born in Palo Alto / San Mateo County, California, youngest of three sisters to Esther and Stanley Wojcicki.

7/28/1973Source
Confidence
100%
1987Age 14

Learned figure skating

At age 14 Wojcicki learned how to figure skate; she later started playing ice hockey.

1/1/1987Source
Confidence
90%
1991Age 18

Edited Gunn High School newspaper; won sports-writing scholarship

Attended Gunn High School in Palo Alto; edited The Oracle and won a scholarship for sports stories.

1/1/1991Source
Confidence
75%
1995Age 22

Molecular biology research at NIH and UC San Diego

Conducted molecular biology research at the National Institutes of Health and at UC San Diego (work performed while a student/early career researcher).

1/1/1995Source
Confidence
75%
1996Age 23

Graduated Yale University (B.S. in Biology)

Received a Bachelor of Science in biology from Yale University; played varsity women's ice hockey while enrolled.

1/1/1996Source
Confidence
99%
1996Age 23

Joined healthcare investment / consulting (Passport Capital, Investor AB)

After graduating, Wojcicki worked as a healthcare consultant at Passport Capital and at Investor AB, and as a healthcare investment analyst overseeing biotech investments.

1/1/1996Net Worth: $200,000Source
Confidence
80%
2000Age 27

Left healthcare investment analyst role after ~4 years

After four years as a healthcare investment analyst, she became disillusioned with Wall Street's approach to health care and decided to pursue building a consumer genomics company.

1/1/2000Net Worth: $500,000Source
Confidence
70%
2005Age 32

Purchased commercial properties in downtown Los Altos (approx.)

Approx. 2005: Wojcicki and then-husband Sergey Brin bought at least half a dozen commercial properties in downtown Los Altos under Passerelle Investment Company.

1/1/2005Net Worth: $3,000,000Source
Confidence
70%
2006Age 33

Co-founded 23andMe

Co-founded 23andMe with Linda Avey and Paul Cusenza to provide direct-to-consumer genetic testing (saliva kits) and empower individuals with access to genetic information.

1/1/2006Net Worth: $1,000,000Source
Confidence
99%
2007Age 33

Married Sergey Brin

Married Google co-founder Sergey Brin (wedding in May 2007).

5/1/2007Net Worth: $20,000,000Source
Confidence
99%
2008Age 35

Birth of first child (son)

Wojcicki and Sergey Brin had a son born in 2008.

1/1/2008Net Worth: $25,000,000Source
Confidence
95%
2008Age 35

23andMe genome test kit named Time's Invention of the Year

Time magazine named 23andMe's personal genome test kit 'Invention of the Year' (2008), raising the company's profile.

1/1/2008Net Worth: $25,000,000Source
Confidence
95%
2009Age 36

Donated $1 million to Hebrew Immigrant Aid Society

Wojcicki and Sergey Brin donated $1 million to support the Hebrew Immigrant Aid Society (HIAS).

1/1/2009Net Worth: $20,000,000Source
Confidence
90%
2011Age 38

Birth of second child (daughter)

Wojcicki and Sergey Brin had a daughter born in late 2011.

1/1/2011Net Worth: $60,000,000Source
Confidence
95%
2012Age 39

Co-founder & board member – Breakthrough Prize (role)

Wojcicki is a co-founder and board member of the Breakthrough Prize in science (organization aimed at recognizing major advances).

1/1/2012Net Worth: $150,000,000Source
Confidence
70%
2013Age 40

Separated from Sergey Brin

Wojcicki and Sergey Brin separated in 2013 after several years of marriage.

1/1/2013Net Worth: $90,000,000Source
Confidence
98%
2013Age 40

FDA regulatory review begins (2013–2015)

From about 2013 to 2015 23andMe underwent regulatory review by the U.S. Food and Drug Administration; during reviews access was limited to ancestry results.

1/1/2013Net Worth: $120,000,000Source
Confidence
90%
2013Age 40

Named 'The Most Daring CEO in America' by Fast Company

Fast Company dubbed Anne Wojcicki 'The Most Daring CEO in America' (October 2013 cover story).

10/1/2013Net Worth: $90,000,000Source
Confidence
95%
2015Age 42

Divorced Sergey Brin (legal divorce)

Wojcicki and Sergey Brin's legal divorce was finalized in 2015.

1/1/2015Net Worth: $150,000,000Source
Confidence
98%
2015Age 42

FDA approval for health-related genetic tests (including >30 autosomal recessive disorders)

Beginning in 2015 the FDA started approving some of 23andMe's health-related tests, including a 2015 approval to market a test detecting more than 30 autosomal recessive disorders.

1/1/2015Net Worth: $160,000,000Source
Confidence
95%
2016Age 43

Passerelle Investment Co. renamed Los Altos Community Investments

The couple's real-estate firm was renamed in 2016 to Los Altos Community Investments with a tighter focus on commercial real-estate development.

1/1/2016Net Worth: $190,000,000Source
Confidence
90%
2016Age 43

23andMe had genotyped over 1 million customers

By 2016 researchers at 23andMe had genotyped more than one million people worldwide, a major community milestone for research power.

1/1/2016Net Worth: $180,000,000Source
Confidence
95%
2016Age 43

Released ResearchKit research module

Released 23andMe's first research-focused module developed with Apple's ResearchKit, enabling researchers to collect data from consenting 23andMe customers.

1/1/2016Net Worth: $185,000,000Source
Confidence
90%
2016Age 43

23andMe community growth target and research opt-in rates reported

23andMe publicly stated goals of 1M, 10M users; Stanford reported that the company had grown to a large community (Stanford noted 12M users and ~80% opt-in to research in later reporting).

1/1/2016Net Worth: $200,000,000Source
Confidence
70%
2018Age 45

Member of Xconomists (editorial/advisory role)

Wojcicki is listed as a member of Xconomists, an ad hoc editorial advisory team for Xconomy (date of membership archived by 2018).

1/1/2018Net Worth: $300,000,000Source
Confidence
70%
2018Age 45

GlaxoSmithKline collaboration / investment announced

In July 2018 23andMe entered a four-year collaboration with GlaxoSmithKline (GSK) to develop new medicines; worth $300 million and giving GSK rights to some discovery programs.

7/1/2018Net Worth: $300,000,000Source
Confidence
98%
2019Age 46

Birth of third child via sperm donation

In July 2019 Wojcicki gave birth to her third child, a daughter, conceived via sperm donation.

7/1/2019Net Worth: $320,000,000Source
Confidence
95%
2020Age 47

Ranked #93 on Forbes' World's 100 Most Powerful Women

Wojcicki was ranked 93rd on Forbes' 2020 list of the World's 100 Most Powerful Women.

1/1/2020Net Worth: $350,000,000Source
Confidence
95%
2021Age 48

SPAC raise reported to be nearly $600M

When taking 23andMe public via SPAC, reporting indicated the SPAC raised nearly $600 million for the transaction.

1/1/2021Net Worth: $1,000,000,000Source
Confidence
85%
2021Age 47

23andMe went public via SPAC merger (took company public)

23andMe took the company public in 2021 through a merger with a special-purpose acquisition company (SPAC); merger reportedly raised nearly $600M and gave 23andMe a peak valuation around $6 billion.

6/1/2021Net Worth: $1,000,000,000Source
Confidence
88%
2021Age 47

Dubbed 'newest self-made billionaire' by Forbes after SPAC

Following the 2021 SPAC public listing Forbes called Anne Wojcicki the 'newest self-made billionaire' based on her stake and the company's valuation.

6/17/2021Net Worth: $1,000,000,000Source
Confidence
80%
2021Age 48

Joined board of Cazoo

Wojcicki joined the board of the UK online car-dealer Cazoo in August 2021.

8/1/2021Net Worth: $950,000,000Source
Confidence
95%
2021Age 48

Opened State Street Market food hall in downtown Los Altos

Los Altos Community Investments opened a food hall called State Street Market and related retail/community initiatives (Sept 2021).

9/7/2021Net Worth: $900,000,000Source
Confidence
90%
2022Age 49

Joined The Giving Pledge

Wojcicki signed The Giving Pledge in 2022, committing to donate most of her wealth.

1/1/2022Net Worth: $270,000,000Source
Confidence
85%
2023Age 50

Major data breach exposed ~6.9M customers' DNA (reported)

In 2023 a data breach reportedly exposed genetic/personal data for approximately 6.9 million customers; this became a major legal and reputational issue for 23andMe.

1/1/2023Net Worth: $200,000,000Source
Confidence
75%
2023Age 50

Business press reports significant net worth decline after stock collapse

After the post-SPAC stock collapse and subsequent company challenges, press reported Wojcicki's net worth had fallen substantially from the 2021 'billionaire' designation to later estimates ($270M reported, then ~$150M in later reporting).

1/1/2023Net Worth: $150,000,000Source
Confidence
70%
2024Age 50

Agreed $30M settlement for data-breach-related lawsuit (reported 2024)

A settlement of roughly $30 million was reported in 2024 related to claims over a 2023 data breach exposing millions of customers' DNA data.

1/1/2024Net Worth: $150,000,000Source
Confidence
70%
2024Age 50

Company valuation fell dramatically (to ~2% of $6B peak)

Reporting in 2024 noted 23andMe's valuation had fallen to roughly 2% of its $6 billion peak valuation, leading to major governance and liquidity challenges.

1/1/2024Net Worth: $50,000,000Source
Confidence
88%
2024Age 51

Take-private buyout offer rejected by 23andMe board

Wojcicki made a buyout offer to take 23andMe private; the company's board rejected her proposal (reported Aug 2024).

8/1/2024Net Worth: $120,000,000Source
Confidence
85%
2024Age 51

Company board resignations

Following the failed take-private effort, all seven independent directors of 23andMe resigned (reported Sept 18, 2024).

9/18/2024Net Worth: $100,000,000Source
Confidence
92%
2025Age 51

23andMe filed Chapter 11; Wojcicki resigned as CEO

23andMe filed for Chapter 11 bankruptcy (March 24, 2025); Anne Wojcicki resigned as CEO effective immediately but remained on the company's board.

3/24/2025Net Worth: $60,000,000Source
Confidence
97%
2025Age 51

Regained control of 23andMe via asset purchase ($305M deal)

On June 13, 2025 Wojcicki bought back nearly all of 23andMe's assets through a reported $305 million deal, regaining control of the company's assets.

6/13/2025Net Worth: $100,000,000Source
Confidence
90%